Skip Navigation



Annals of Oncology Advance Access published online on June 25, 2009
Annals of Oncology, doi:10.1093/annonc/mdp196
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/10/1631    most recent
mdp196v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Verleye, L.
Right arrow Articles by Ottevanger, P. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verleye, L.
Right arrow Articles by Ottevanger, P. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

review

Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer—Gynecological Cancer Group (EORTC-GCG)

L. Verleye1,*, I. Vergote2, N. Reed3 and P. B. Ottevanger4

1 EORTC Headquarters, Brussels
2 Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Belgium
3 Beatson Oncology Centre, Gartnavel General Hospital, Glasgow, UK
4 Division Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

* Correspondence to: Dr L. Verleye, EORTC Headquarters, Avenue E. Mounierlaan 83/11, B-1200 Brussels, Belgium. Tel: +32-2-774-10-73; Fax: +32-2-771-38-10; E-mail: Leen.Verleye{at}eortc.be

Radical hysterectomy combined with a pelvic lymphadenectomy or chemoradiation are traditionally the mainstays of treatment of International Federation of Gynecology and Obstetrics stages Ia2–IIa cervical cancer. The quality of radical surgery for cervical cancer influences local tumor control and survival. Hence, it is important to optimize and ensure the quality of surgical care for cervical cancer patients. In this paper, we discuss factors that are related to outcome after radical hysterectomy and propose a set of quality indicators that can be used to audit and improve the quality of surgical care for cervical cancer patients.

quality assurance, radical hysterectomy, surgery, uterine cervical neoplasms

Received for publication November 26, 2008. Revision received March 2, 2009. Accepted for publication March 3, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.